The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
2019 · BMC Cancer · 27 citations
https://doi.org/10.1186/s12885-019-6244-6
N
Nada Albarakati
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
691
Citations
12
h-index
12
i10-index
Nada Albarakati is an academic researcher from King Saud bin Abdulaziz University for Health Sciences. The author has contributed to research in topics: DNA Repair Mechanisms & Cancer-related Molecular Pathways & Genomics and Chromatin Dynamics. The author has an h-index of 12, co-authored 21 publications.
ORCID: 0000-0001-5135-8684Papers by this author
worksInteraction between <scp>HER2</scp> and <scp>ATM</scp> predicts poor survival in bladder cancer patients
2022 · Journal of Cellular and Molecular Medicine · 9 citations
https://doi.org/10.1111/jcmm.17512
Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients
2023 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-023-38923-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat